diazooxonorleucine has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alt, J; Brandacher, G; Chao, W; Dash, RP; Furtmüller, G; Gadiano, AJ; Garrett, C; Hadas, E; Jančařík, A; Kelschenbach, J; Kim, BH; Majer, P; Nedelcovych, MT; Oh, B; Prchalová, E; Rais, R; Slusher, BS; Tenora, L; Volsky, DJ; Zimmermann, SC | 1 |
1 other study(ies) available for diazooxonorleucine and HIV Coinfection
Article | Year |
---|---|
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.
Topics: Aminocaproates; Animals; Azo Compounds; Blood; Brain; Diazooxonorleucine; Drug Stability; Female; Glutamic Acid; Glutaminase; HIV Infections; Humans; Male; Mice, Inbred C57BL; Neurocognitive Disorders; Nootropic Agents; Prodrugs; Swine; Viral Load | 2017 |